Eli Lilly stock jumps as drugmaker raises outlook on booming diabetes and obesity sales

Eli Lilly stock jumped as the drugmaker raised its outlook on booming sales of its diabetes and obesity treatments.

Detected & updated continuously · Source: Nebula